• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性红斑狼疮患者疾病活动模式随时间的变化:霍普金斯狼疮队列分析

Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort.

作者信息

Györi Noémi, Giannakou Ioanna, Chatzidionysiou Katerina, Magder Laurence, van Vollenhoven Ronald F, Petri Michelle

机构信息

ClinTRID-Unit for Clinical Therapy Research, Inflammatory Diseases, Department of Medicine , Karolinska University Hospital, Karolinska Institute , Stockholm , Sweden.

Division of Rheumatology , School of Medicine, Johns Hopkins University , Baltimore, MD , USA.

出版信息

Lupus Sci Med. 2017 Feb 8;4(1):e000192. doi: 10.1136/lupus-2016-000192. eCollection 2017.

DOI:10.1136/lupus-2016-000192
PMID:28243457
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5307372/
Abstract

OBJECTIVE

To describe SLE disease activity patterns in the Hopkins Lupus Cohort.

METHODS

Disease activity was studied in 1886 patients followed-up for 1-28 years. Disease activity patterns were defined using (1) Physician Global Assessment (PGA) and (2) modified SLE Disease Activity Index (M-SLEDAI) as follows: long quiescent (LQ), M-SLEDAI=0/PGA=0 at all visits; relapsing-remitting (RR), periods of activity (M-SLEDAI>0/PGA>0) interspersed with inactivity (M-SLEDAI=0/PGA=0); chronic active (CA), M-SLEDAI>0/PGA>0 at all visits. The pattern of first 3 consecutive follow-up years was determined in 916 patients as: persistent LQ (pLQ), persistent RR (pRR) and persistent CA (pCA), LQ, RR and CA pattern in each of the 3 years, respectively; mixed, at least two different pattern types were identified.

RESULTS

The RR pattern accounted for the greatest proportion of follow-up time both by M-SLEDAI and PGA, representing 53.8% and 49.9% of total patient-years, respectively. The second most frequent pattern was LQ based on M-SLEDAI (30.7%) and CA based on PGA (40.4%). For the first 3-year intervals, the mixed pattern type was the most common (56.6%). The pRR was the second most frequent (M-SLEDAI 33.3%, PGA 26.5%), while pLQ (M-SLEDAI 6.4%, PGA 0.7%) and pCA were less frequent (M-SLEDAI 3.7%, PGA 16.3%).

CONCLUSIONS

The RR pattern was the most prevalent pattern. LQ was achieved in a subset of patients, using the M-SLEDAI. However, the PGA captured mild activity missed on the M-SLEDAI in these patients. Over a 3-year perspective, less than half of patients maintained their original pattern.

摘要

目的

描述霍普金斯狼疮队列中的系统性红斑狼疮(SLE)疾病活动模式。

方法

对1886例患者进行了1至28年的随访,研究疾病活动情况。疾病活动模式定义如下:(1)医生整体评估(PGA);(2)改良SLE疾病活动指数(M-SLEDAI):长期缓解(LQ),所有随访时M-SLEDAI = 0/PGA = 0;复发缓解型(RR),活动期(M-SLEDAI>0/PGA>0)与非活动期(M-SLEDAI = 0/PGA = 0)交替出现;慢性活动型(CA),所有随访时M-SLEDAI>0/PGA>0。在916例患者中确定了连续3年首次随访的模式为:持续长期缓解(pLQ)、持续复发缓解(pRR)和持续慢性活动(pCA),即3年中每年分别为LQ、RR和CA模式;混合型,至少识别出两种不同的模式类型。

结果

RR模式在M-SLEDAI和PGA评估中占随访时间的比例最大,分别占总患者年数的53.8%和49.9%。基于M-SLEDAI的第二常见模式是LQ(30.7%),基于PGA的是CA(40.4%)。在最初的3年间隔中,混合型最常见(56.6%)。pRR是第二常见的(M-SLEDAI为33.3%,PGA为26.5%),而pLQ(M-SLEDAI为6.4%,PGA为0.7%)和pCA较少见(M-SLEDAI为3.7%,PGA为16.3%)。

结论

RR模式是最普遍的模式。使用M-SLEDAI时,一部分患者实现了长期缓解。然而,PGA发现了这些患者中M-SLEDAI遗漏的轻度活动。从3年的角度来看,不到一半的患者维持了其最初的模式。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f969/5307372/9a0930eccef7/lupus2016000192f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f969/5307372/9a0930eccef7/lupus2016000192f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f969/5307372/9a0930eccef7/lupus2016000192f01.jpg

相似文献

1
Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort.系统性红斑狼疮患者疾病活动模式随时间的变化:霍普金斯狼疮队列分析
Lupus Sci Med. 2017 Feb 8;4(1):e000192. doi: 10.1136/lupus-2016-000192. eCollection 2017.
2
Patterns of disease activity in systemic lupus erythematosus.系统性红斑狼疮的疾病活动模式
Arthritis Rheum. 1999 Dec;42(12):2682-8. doi: 10.1002/1529-0131(199912)42:12<2682::AID-ANR26>3.0.CO;2-6.
3
Impact of disease activity patterns on health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE).系统性红斑狼疮患者疾病活动模式对健康相关生活质量(HRQoL)的影响。
Lupus Sci Med. 2024 Jul 29;11(2):e001202. doi: 10.1136/lupus-2024-001202.
4
Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus Cohort.系统性红斑狼疮持续疾病活动和长期缓解的预测因素:霍普金斯狼疮队列研究结果
Lupus Sci Med. 2018 Nov 2;5(1):e000287. doi: 10.1136/lupus-2018-000287. eCollection 2018.
5
Validity and reliability of retrospective assessment of disease activity and flare in observational cohorts of lupus patients.狼疮患者观察性队列中疾病活动度和病情复发回顾性评估的有效性和可靠性
Lupus. 1999;8(8):638-44. doi: 10.1191/096120399680411443.
6
The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.修订后的系统性狼疮活动度量表、墨西哥系统性红斑狼疮疾病活动指数(SLEDAI)以及改良的SLEDAI-2K是用于测量系统性红斑狼疮疾病活动度的合适工具。
J Rheumatol. 2004 Oct;31(10):1934-40.
7
Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.单中心队列系统性红斑狼疮患者疾病活动模式:一项为期七年的随访研究。
Clin Exp Rheumatol. 2012 Nov-Dec;30(6):856-63. Epub 2012 Dec 17.
8
Treatment Patterns and Clinical Characteristics of Patients with Systemic Lupus Erythematosus and Musculoskeletal Symptoms: A Retrospective, Observational Study.以回顾性、观察性研究方法探讨有肌肉骨骼症状的系统性红斑狼疮患者的治疗模式和临床特征。
Adv Ther. 2022 Jul;39(7):3131-3145. doi: 10.1007/s12325-022-02148-8. Epub 2022 May 9.
9
A pilot study to determine the optimal timing of the Physician Global Assessment (PGA) in patients with systemic lupus erythematosus.一项确定系统性红斑狼疮患者医师整体评估(PGA)最佳时机的初步研究。
Immunol Res. 2015 Dec;63(1-3):167-9. doi: 10.1007/s12026-015-8712-7.
10
Associations between physicians' global assessment of disease activity and patient-reported outcomes in patients with systemic lupus erythematosus: A longitudinal study.红斑狼疮患者疾病活动的医生整体评估与患者报告结局之间的关联:一项纵向研究。
Lupus. 2021 Sep;30(10):1586-1595. doi: 10.1177/09612033211027943. Epub 2021 Jul 1.

引用本文的文献

1
Frequency and Determinants of Flare and Persistently Active Disease in a Large Multinational Prospective Lupus Cohort.一个大型跨国前瞻性狼疮队列中疾病发作和持续活动性疾病的频率及决定因素
ACR Open Rheumatol. 2025 Mar;7(3):e70007. doi: 10.1002/acr2.70007.
2
Time trends of variability in disease activity in systemic lupus erythematosus.系统性红斑狼疮疾病活动度变异性的时间趋势
Lupus Sci Med. 2025 Feb 12;12(1):e001335. doi: 10.1136/lupus-2024-001335.
3
Identifying meaningful aspects of health and concepts of interest for assessment in systemic lupus erythematosus: implications for digital clinical measure development.

本文引用的文献

1
Prolonged remission in Caucasian patients with SLE: prevalence and outcomes.白种人系统性红斑狼疮患者的长期缓解:患病率和结局。
Ann Rheum Dis. 2015 Dec;74(12):2117-22. doi: 10.1136/annrheumdis-2015-207347. Epub 2015 Jul 29.
2
Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight.系统性红斑狼疮达标治疗的价值与目标:知识与远见
Lupus. 2015 Apr;24(4-5):507-15. doi: 10.1177/0961203314559087.
3
Prolonged clinical remission in patients with systemic lupus erythematosus.系统性红斑狼疮患者的临床缓解延长。
确定系统性红斑狼疮中健康的有意义方面和评估感兴趣的概念:对数字临床测量发展的影响。
J Patient Rep Outcomes. 2024 Dec 24;8(1):154. doi: 10.1186/s41687-024-00832-7.
4
Trajectories of disease severity and their clinical outcome in real-world patients with systemic lupus erythematosus.系统性红斑狼疮真实世界患者的疾病严重程度轨迹及其临床结局
Heliyon. 2024 Oct 1;10(20):e38705. doi: 10.1016/j.heliyon.2024.e38705. eCollection 2024 Oct 30.
5
Impact of disease activity patterns on health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE).系统性红斑狼疮患者疾病活动模式对健康相关生活质量(HRQoL)的影响。
Lupus Sci Med. 2024 Jul 29;11(2):e001202. doi: 10.1136/lupus-2024-001202.
6
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring.SMART-SLE:系统性红斑狼疮的血清学监测和重复检测——抗双链 DNA 监测分析。
Rheumatology (Oxford). 2024 Feb 1;63(2):525-533. doi: 10.1093/rheumatology/kead231.
7
Validation and the associated factors of the Malay version of systemic lupus erythematosus-specific health-related quality of life questionnaires (SLEQoL and LupusQoL).验证和相关因素的马来语版本的系统性红斑狼疮特异性健康相关生活质量问卷 (SLEQoL 和 LupusQoL)。
PLoS One. 2023 May 15;18(5):e0285461. doi: 10.1371/journal.pone.0285461. eCollection 2023.
8
Prolonged oral corticosteroid treatment in patients with systemic lupus erythematosus: An evaluation of 12-month economic and clinical burden.系统性红斑狼疮患者的长期口服皮质类固醇治疗:12 个月经济和临床负担评估。
J Manag Care Spec Pharm. 2023 Apr;29(4):365-377. doi: 10.18553/jmcp.2023.29.4.365.
9
Risk of systemic lupus erythematosus flares according to autoantibody positivity at the time of diagnosis.根据诊断时自身抗体阳性情况评估系统性红斑狼疮发作风险。
Sci Rep. 2023 Feb 21;13(1):3068. doi: 10.1038/s41598-023-29772-w.
10
Altered B cell phenotype and CD27+ memory B cells are associated with clinical features and environmental exposure in Colombian systemic lupus erythematosus patients.哥伦比亚系统性红斑狼疮患者的B细胞表型改变及CD27⁺记忆B细胞与临床特征和环境暴露相关。
Front Med (Lausanne). 2022 Sep 6;9:950452. doi: 10.3389/fmed.2022.950452. eCollection 2022.
J Rheumatol. 2014 Sep;41(9):1808-16. doi: 10.3899/jrheum.131137. Epub 2014 Aug 1.
4
Optimizing outcome in SLE: treating-to-target and definition of treatment goals.优化 SLE 结局:达标治疗及治疗目标的定义。
Autoimmun Rev. 2014 Jul;13(7):770-7. doi: 10.1016/j.autrev.2014.01.055. Epub 2014 Jan 27.
5
Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study.单中心队列系统性红斑狼疮患者疾病活动模式:一项为期七年的随访研究。
Clin Exp Rheumatol. 2012 Nov-Dec;30(6):856-63. Epub 2012 Dec 17.
6
Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.系统性红斑狼疮国际协作临床分类标准的推导与验证
Arthritis Rheum. 2012 Aug;64(8):2677-86. doi: 10.1002/art.34473.
7
Outcomes in patients with systemic lupus erythematosus with and without a prolonged serologically active clinically quiescent period.伴有和不伴有长时间血清学活动性临床静止期的系统性红斑狼疮患者的结局。
Arthritis Care Res (Hoboken). 2012 Apr;64(4):511-8. doi: 10.1002/acr.21568.
8
Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome.持续性血清学活动但临床无症状的系统性红斑狼疮:频率与结局。
J Rheumatol. 2010 Sep;37(9):1822-7. doi: 10.3899/jrheum.100007. Epub 2010 Jul 1.
9
Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus.在一个多国家系统性红斑狼疮患者的起始队列中,在疾病早期过程中疾病活动和损伤累积的情况。
Lupus. 2010 Jul;19(8):949-56. doi: 10.1177/0961203310366572. Epub 2010 Apr 7.
10
SLE disease patterns in a Danish population-based lupus cohort: an 8-year prospective study.丹麦基于人群的狼疮队列中的 SLE 疾病模式:一项 8 年前瞻性研究。
Lupus. 2010 Mar;19(3):239-46. doi: 10.1177/0961203309351033. Epub 2009 Nov 27.